Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer (Q83116154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Jiunn-Bey Pao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ying-Pi Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chun-Nung Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shu-Pin Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Tzyh-Chyuan Hour

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ta-Yuan Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yu-Hsuan Lan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Te-Ling Lu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hong-Zin Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shin-Hun Juang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chao-Yuan Huang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

23 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

281-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22193519%20AND%20SRC:MED&resulttype=core&format=json

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer

19 January 2020

cites work

1 reference

12 December 2020

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

1 reference

12 December 2020

Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer.

1 reference

12 December 2020

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

1 reference

12 December 2020

Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure

1 reference

12 December 2020

Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population

1 reference

12 December 2020

Vitamin D pathway gene variants and prostate cancer prognosis

1 reference

12 December 2020

Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.

1 reference

12 December 2020

A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women

1 reference

12 December 2020

The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.

1 reference

12 December 2020

Mechanisms underlying the development of androgen-independent prostate cancer.

1 reference

12 December 2020

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

1 reference

12 December 2020

Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients

1 reference

12 December 2020

Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies

1 reference

12 December 2020

Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer

1 reference

12 December 2020

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

1 reference

12 December 2020

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer

1 reference

12 December 2020

Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy

1 reference

12 December 2020

Prostate cancer: a practical approach to current management of recurrent disease

1 reference

12 December 2020

Hormonotherapy of advanced prostate cancer.

1 reference

12 December 2020

Genetics and biology of vitamin D receptor polymorphisms

1 reference

12 December 2020

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

1 reference

12 December 2020

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

1 reference

12 December 2020

Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells

1 reference

12 December 2020

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review

1 reference

12 December 2020

The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene

1 reference

12 December 2020